.png)
What is Parenteral Packaging?
Parenteral packaging refers to the materials and containers used for the packaging of parenteral drugs, which are administered by injection or infusion. This type of packaging is crucial to ensure the safety, sterility, and efficacy of drugs, preventing contamination and ensuring the correct dosage and administration. It includes a wide range of products, such as syringes, vials, ampoules, cartridges, and prefilled pens, all designed to withstand the conditions required for storing and transporting injectable medications. As the pharmaceutical industry continues to innovate, the parenteral packaging market plays a vital role in enhancing drug delivery systems.
Parenteral Packaging Market was valued at USD 9.5 billion in 2023 and is projected to grow to USD 10.68 billion in 2024. The market is expected to continue its upward trajectory, reaching USD 27.39 billion by 2032, reflecting a compound annual growth rate (CAGR) of 12.49% from 2024 to 2032.
USA Growing Parenteral Packaging Market
The parenteral packaging market in the USA is experiencing robust growth, driven by the increasing demand for biologics, vaccines, and injectable drugs. The global shift toward personalized medicine, coupled with advancements in drug delivery technologies, has further fueled the need for high-quality and secure packaging solutions. The USA, with its strong pharmaceutical and biotechnology industries, remains a dominant player in the market. The rising demand for sophisticated drug packaging that ensures patient safety, combined with innovations in packaging materials, is expected to continue driving market growth in the coming years.
Global Growth Insights unveils the top List global Parenteral Packaging Companies:
- Gerresheimer AG
- Headquarters: Düsseldorf, Germany
- Revenue: €1.4 billion (2023)
- CAGR: Gerresheimer has seen steady growth in the parenteral packaging segment, largely due to the demand for its high-quality glass and plastic containers. The company is focused on expanding its product offerings and increasing its presence in emerging markets.
- Schott AG
- Headquarters: Mainz, Germany
- Revenue: €2.5 billion (2023)
- CAGR: Schott AG continues to invest in advanced technologies, particularly in the development of high-quality glass vials and syringes for injectable drugs. Their innovation and dedication to research have helped them maintain a leading position in the parenteral packaging market.
- SiO2 Materials Science
- Headquarters: Auburn, Alabama, USA
- Revenue: $150 million (2023)
- CAGR: SiO2 Materials Science is gaining traction in the market with its advanced hybrid glass-plastic technology, which improves the safety and efficiency of injectable drug packaging. The company is poised for significant growth as demand for innovative packaging solutions increases.
- Unilife Corporation
- Headquarters: York, Pennsylvania, USA
- Revenue: $25 million (2019, prior to ceasing operations)
- CAGR: Unilife Corporation, while having ceased operations, was once a key player in the development of innovative drug delivery systems, including prefilled syringes. The company’s exit from the market, however, does not overshadow the progress made in the parenteral packaging sector.
- Ypsomed AG
- Headquarters: Burgdorf, Switzerland
- Revenue: CHF 497 million (2023)
- CAGR: Ypsomed has established itself as a leader in the development of prefilled syringes and pen injectors. Their focus on creating user-friendly drug delivery systems has allowed them to capture a significant share of the global parenteral packaging market.
- Becton, Dickinson and Company (BD)
- Headquarters: Franklin Lakes, New Jersey, USA
- Revenue: $20.3 billion (2023)
- CAGR: BD remains one of the largest players in the medical technology sector, with its parenteral packaging solutions continuing to be a cornerstone of its business. The company's strong focus on innovation and customer needs has allowed it to maintain its dominance in the market.
- West Pharmaceutical Services, Inc.
- Headquarters: Exton, Pennsylvania, USA
- Revenue: $2.8 billion (2023)
- CAGR: West Pharmaceutical Services has seen considerable growth due to its focus on developing advanced packaging systems for injectable medications. Their high-quality elastomeric closures, along with other packaging solutions, are widely used in the pharmaceutical industry.
Parenteral Packaging Conclusion
The parenteral packaging market is poised for continued expansion, driven by technological advancements and the growing demand for injectable medications. Companies like Gerresheimer AG, Schott AG, and Becton, Dickinson, and Company are leading the charge with innovative packaging solutions that enhance drug safety, efficiency, and patient experience. As the global pharmaceutical industry embraces new drug delivery methods, the need for secure and reliable parenteral packaging will only increase. The USA's position as a key market player, coupled with continued investments in research and development, ensures that parenteral packaging will remain a critical component of the healthcare landscape for years to come.